Group | IV-PCA | RSB | ITMB | Â |
---|---|---|---|---|
n | 30 | 30 | 30 | p |
Requirement of opioid infusion | ||||
 Cumulative IV-PCA infusion (mL) | 37.6 (25.9–57.3) | 42.8 (29.9–60.8) | 18.7 (14.7–26.2)*, †| < 0.001 |
 IV rescue opioid infusion | 19 (63.3%) | 21 (70.0%) | 6 (20.0%)*, †, ‡ | < 0.001 |
Peak visual analog scale | ||||
 at rest | 6 (4–7) | 5 (4–6) | 3 (2–4)*, †| < 0.001 |
 at cough | 8 (6–9) | 6 (5–7)* | 4 (3–5)*, †| < 0.001 |
Quality of early recovery | ||||
 Global score of QoR-15 questionnaire on POD 1 | 124 (122–129) | 124 (117–133) | 130 (126–141)*,†| 0.002 |
Complications | ||||
 Nausea | 2 (6.7%) | 2 (6.7%) | 9 (30.0%)‡ | 0.012 |
 Vomiting | 0 (0.0%) | 1 (3.3%) | 2 (6.7%) | 0.355 |
 Pruritus | 0 (0.0%) | 0 (0.0%) | 5 (16.7%)‡ | 0.005 |
Laboratory variables on POD 1 | ||||
 White blood cell count (× 109/L) | 13.5 (8.7–16.5) | 15.4 (8.2–20.7) | 14.3 (11.2–19.3) | 0.478 |
  Neutrophil (%) | 172.0 (141.0–203.3) | 175.5 (154.0–211.8) | 168.0 (151.3–201.0) | 0.873 |
  Lymphocyte (%) | 73.5 (69.1–76.5) | 73.1 (68.0–78.7) | 71.4 (65.1–78.9) | 0.807 |
 Hemoglobin (g/dL) | 8.8 (7.4–11.0) | 7.8 (7.1–9.1) | 8.7 (6.6–10.3) | 0.476 |
 Platelet count (× 109/L) | 12.6 (11.7–13.4) | 12.2 (11.0–13.5) | 12.3 (11.7–12.9) | 0.419 |
 International normalized ratio | 1.0 (0.8–1.0) | 0.9 (0.9–1.0) | 0.9 (0.8–1.0) | 0.072 |